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Rat peritoneal mast cells were used to study the effects of digitalis glycosides on potassium uptake and histamine release induced by compound 
48/80, substance P and egg-albumin (immunological release). In the absence of calcium all glycosides inhibited potassium uptake. Ouabain and 
digoxin enhanced the histamine release while digitoxigenin either had no effect or was slightly inhibitory. In the presence of calcium, the glycosides 
only affected potassium uptake and histamine release slightly. In the presence of lithium or lanthanum the enhancement of the histamine release 
was counteracted. Hydrophilic digitalis glycosides eem to enhance histamine release secondary to an increase in intracellular sodium. Lipophilic 
glycosides have no effect on the release. 
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1. INTRODUCTION 
The digitalis glucoside ouabain, enhances histamine 
release from mast cells incubated in a calcium-free me- 
dium [l-4]. The Na+/K’-pump in the plasma membrane 
of mast cells [5] is inhibited by ouabain, and this allows 
the accumulation of sodium inside the cells. The en- 
hancement by ouabain of histamine release develops 
gradually over 0.4-l h [2,3], and it is likely to be related 
to the accumulation of sodium, which may induce 
changes in a pool of calcium bound to the plasma mem- 
brane [4]. Erjavec and Ferjan [6] reported that hydro- 
philic digitalis glycosides enhance histamine release 
from rat mast cells induced by compound 48/80, while 
more lipophilic glycosides inhibit histamine release. 
Measurements of the activity of the Na’/K’-pump was, 
however, not performed in that study. 
The aim of this investigation was to compare the 
effect of three digitalis glycosides (ouabain, digoxin and 
digitoxigenin) on the release of histamine from rat mast 
cells with the effect of the glycosides on Na’/K+-pump 
activity (the ouabain-sensitive potassium uptake). 
While ouabain is hydrophilic and digitoxigenin is lipo- 
philic, digoxin is in between [7]. Additionally it was 
studied whether the mechanism behind ouabain en- 
hancement of compound 48/80-induced histamine re- 
lease also applied to release induced by substance P or 
egg-albumin (immunological release). 
Measurements of cellular potassium uptake was per- 
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formed by use of 86Rb+ as a tracer for potassium 
(K’(86Rb+)-uptake). 
2. MATERIALS AND METHODS 
2.1. Isolation of mast cells 
Male SpragueDawley rats, 2OfUOO g, were used for the experi- 
ments with compound 48/80 and substance P, and male Wistar rats, 
340-440 g, were used for the experiments with egg-albumin. The rats 
were killed by decapitation under light ether anaesthesia. 10 ml of 
Krebs-Ringer solution was prewarmed to 37’C and injected into the 
abdominal cavity through a small incision in the abdominal wall. After 
massage for 1 min, the Krebs-Ringer solution containing mixed peri- 
toneal cells was aspirated. The peritoneal mast cells were isolated on 
a self-generating radient of Percoll as previously described [5]. The 
cells were suspended in an appropriate volume of Krebs-Ringer solu- 
tion for the experiments. 
The number of cells was measured by an automatic ell counter, and 
the purity of the suspensions was determined by inspection of stained 
(Toluidine blue) smears. The fraction of mast cells was 98.6 f 1.2% 
(mean f SD., n = 40). 
2.2. Sensitization of the rats 
Male Wistar rats were sensitized to egg-albumin by injecting 1 ml 
of pertussis vaccine with 25 mg of egg-albumin subcutaneously on the 
first day, followed by booster doses of 25 mg on the second and the 
third day. On the second day, the booster dose was given together with 
0.5 ml of Freund’s incomplete adjuvant. The rats were used 36 weeks 
after the first injection. 
2.3. Incubation procedure 
Mast cell suspensions pooled from l-7 rats were divided into sam- 
ples containing equal numbers of cells and preincubated in a final 
volume of 400 ~1 at 37°C. The details regarding time of preincubation 
and the presence of various chemicals and drugs are given in the 
legends to the figures. All calculations are based on duplicate samples. 
When histamine release was induced immunologically (egg albumin), 
the preincubation was performed in the presence of phosphatidyl- 
serine, 0.05 mg . ml-‘, which is known to enhance immunologically 
induced histamine release [8]. Each sample contained between 
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5.8 x lo4 and 3.7 x 10’ cells. Following the preincubation period, 100 
~1 of a Krebs-Ringer solution containing either trace amounts of 
“Rb+ (for the determination of the K’(86Rb’)-uptake) or histamine 
secretagogues (for determination of the histamine release) were added, 
and the cells were incubated for 10 min. The incubation was termi- 
nated by addition of 9.5 ml (K+(86Rbf)-uptake) or 1.75 ml (histamine 
release) of ice-chilled Krebs-Ringer solution. 
2.4. Measurement of the @Rb+-uptake of mast cells 
The concentration of *‘Rb+ during the incubation of the cells was 
between 1 and 150 PM, and the specific activity was 11.7 MBq per 
mmol of K+, while the radioactive concentration was kept at 1.5 @Zi 
ml-‘. The incubation was terminated and the cellular potassium up- 
take calculated as described elsewhere [4]. In Fig. 3, the ouabain- 
sensitive K’(86Rb’)-uptake is shown. This is equivalent o the differ- 
ence in uptake between cells incubated in the absence and presence of 
1 mM ouabain. 
2.5. Measurement of cellular histamine release 
The concentrations of the histamine releasers during the incubation 
of the cells were as follows: compound 48/80, 1.0 pug ml-‘; substance 
P, 30 PM, and egg-albumin, 0.5 mg ml-‘. After termination of the 
incubation, the histamine release was determined fluorimetrically as 
previously described [4]. The histamine release was expressed as a 
percentage of the total histamine content of the cells and presented 
after subtraction of the spontaneous histamine release from cells incu- 
bated in the absence of the histamine releasers. The spontaneous 
histamine release was always less than 8.38, except for the experi- 
ments in which extracellular sodium was substituted with lithium (Fig. 
3). The spontaneous histamine release in the presence of lithium was 
up to 16.8% (range 14.2-16.8%). The digitalis glycosides and lantha- 
num had no significant effect on the spontaneous histamine release. 
2.6. Solutions 
The calcium-free Krebs-Ringer solution had the following compo- 
sition (in mM): NaCl 136, KC1 4.75, MgSO, 1.2, Tris-HCl 12.5. The 
calcium-containing Krebs-Ringer solution contained (in mM): NaCl 
134, KC1 4.75, CaCl, 1.0, MgSO, 1.2, Tris-HCl 12.5. In some of the 
experiments shown in Fig. 3, NaCl was substituted with an equimolar 
concentration of LiCl. All solutions contained bovine serum albumin, 
1 mg . ml-‘, and glucose, 1 mg ml-‘. The pH was 7.4 (room temper- 
ature). 
2.7. Materials 
Bovine serum albumin, digoxin, digitoxigenin, compound 48/80, 
substance P and phosphatidylserine was supplied by Sigma Chemical 
Co. (St. Louis, USA), glucose and dimethylsulphoxide (DMSO) by 
Merck (Darmstadt, Germany), Percoll by Pharmacia Fine Chemicals 
(Sweden), scintillation liquid (Ecoscint) by BN Plastics (Helsinge, 
Denmark), 86Rb+ (specific activity 1-12 MCi/mg Rb’) by Amersham 
(Buckinghamshire, UK), ouabain by Mecobenzon (Denmark), egg- 
albumin by Mallicrodt Chemical Work (St. Louis, USA). Freunds 
incomplete adjuvant and pertussis vaccine was supplied by Statens 
Serum Institut (Denmark). All other chemicals were of analytical 
grade. Ouabain was prepared as a 5 mM stock solution by dissolution 
in Krebs-Ringer solution. Digoxin and digitoxigenin were prepared 
as a 30 mM stock solution by dissolution in DMSO and diluted with 
Krebs-Ringer solution for the experiments. The concentration of 
DMSO during the experiments was maximally 1.7% (v/v). When di- 
goxin and digitoxigenin were used, the control samples contained the 
same concentrations of DMSO but were without the glycosides. Com- 
pound 48/80 was prepared as a 1 mg ml-’ stock solution by dissolu- 
tion in 0.9% saline. Phosphatidylserine was prepared as a 0.5 mg ml-’ 
stock solution by dissolution in Krebs-Ringer solution. Substance P
was preared as a 500 PM stock solution by dissolution in Krebs- 
Ringer solution. 
2.8. Presentation of results 
All results are shown as mean f S.E.M. of five experiments. The 
128 
Mann-Whitney U-test was used for the statistical analysis of the data. 
P < 0.05 was chosen as the threshold level of significance. 
3. RESULTS 
The effect of ouabain, digoxin and digitoxigenin on 
cellular K+(86Rb’)-uptake is shown in Fig. 1. While lo-’ 
M of the three drugs had no effect on the uptake, it was 
decreased in the presence of 10e4 M of the drugs. A 
maximal decrease to 20 ? 2% of the control value was 
observed with 10V3 M ouabain. Concentrations of the 
glycosides less than low5 M tended to increase the cellu- 
lar uptake of potassium. The control values were (in 
pmol/106 cells/min): 463 + 76 (ouabain), 461 & 48 (di- 
goxin) and 695 + 130 (digitoxigenin). 
Fig. 2 shows the effect of ouabain, digoxin and dig- 
itoxigenin on cellular K+(“Rb+)-uptake and release of 
histamine induced by compound 48/80 (a), egg-albumin 
(b) and substance P (c). The same pattern of responses 
to the drug treatment were found with the three secre- 
tagogues. In a calcium-free medium the cellular uptake 
of K+(*‘Rb+) was inhibited by 10e4 M of digoxin, dig- 
itoxigenin and ouabain, as well as of 10V3 M ouabain. 
Except for digitoxigenin, which had no effect on hista- 
mine release, these drugs also enhanced the release of 
histamine. These effects were statistically significant ex- 
cept for the values (in Fig. 2a) of cellular K+(86Rbf)- 
uptake in presence of 10m4 M of digoxin, digitoxigenin 
and ouabain. In the presence of calcium the drugs had 
no effect on the cellular K’(86Rb’)-uptake. However, a 
slight increase, that reached the level of significance, 
was observed in the presence of 1 0m4 M digoxin and 10m3 
M ouabain (Fig. 2~). In general, the drugs had only 
minor and mostly insignificant effects on the release of 
histamine in a calcium-containing medium. It is demon- 
6 
E 120- 
z 
5 loo- 
B 
g 80- 
z 
I 
- $ 60- 
c m- 
+Y 
2 zo- 
$,I,, 1 , , , , , 
I I I I 
10-S 10-7 10-e 10-s 10-d 10-3 
Concentration of drugs(M) 
Fig. 1. Effect of ouabain, digoxin and digitoxigenin on the cellular 
K’(86Rb’)-uptake. The cells were preincubated for 60 min at 37°C in 
a calcium-free medium containing 4.75 mM potassium and ouabain 
(o), digoxin (0) or digitoxigenin (A) in concentrations as indicated on 
the abscissa scale. Control samples without the glycosides were run in 
parallel. After preincubation lOO@ of Krebs-Ringer solution contain- 
ing “Rb+ was added and the cells were incubated for 10 min. The 
ordinate scale shows the K’(@Rb’)-uptake as a percentage of the 
control values. 
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Fig. 2. Effect of ouabain, digoxin and digitoxigenin on cellular K’(86Rb’)-uptake and histamine release induced by compound 48180 (a), egg albumin 
(b) and substance P (c). The cells were preincubated for 60 min at 37°C in the absence or presence of 1 mM calcium in a medium containing 4.75 
mM potassium and in the presence of the glycosides as indicated. Control samples without the glycosides were run in parallel. Following 
preincubation lOO@ of Krebs-Ringer solution containing either *‘Rb+ (for determination of K’(S6Rb’)-uptake) or compound 48/80 (a), egg-albumin 
(b), substance P (c) (for determination of cellular histamine release) was added and the cells were incubated for 10 min. For determination of 
spontaneous histamine release, samples without the secretagogues were run in parallel. The left hand scale shows the K+(86Rb+)-uptake of the cells 
in pmol/106 cells/min (open columns), while the right hand scale shows the histamine release as a percentage of the total histamine content of the 
sample (hatched columns). *P < 0.05; **P < 0.01. 
strated in Fig. 2a-c that, compared with control values 
from cells incubated without any drug or DMSO, the 
inclusion of DMSO (1.7% v/v) did not change the values 
for K+(s6Rb+)-uptake or histamine release induced by 
the three secretagogues either in the presence or in the 
absence of extracellular calcium. 
Fig. 3 shows the effect of LaCl, and the replacement 
of extracellular sodium for lithium on the ouabain-sen- 
sitive K+(86Rbf)-uptake and cellular histamine release 
induced by compound 48/80, egg-albumin and sub- 
stance P. There was a large inhibition of the ouabain- 
sensitive K+(“Rb+)-uptake by incubation of the cells 
with 1 PM LaCl, or replacement of sodium for lithium 
in the three groups of experiments. 
Histamine release induced by the three secretagogues 
was increased significantly by addition of 10W3 M 
ouabain. Ouabain had no effect on the release of hista- 
mine when sodium was replaced with lithium. Addition 
of ouabain to LaCl,-treated cells caused a small but 
significant increased histamine release with compound 
48/80 and egg-albumin. In the presence of LaCl,, the 
histamine release induced by substance P was not 
changed significantly by addition of ouabain. 
4. DISCUSSION 
The moderate decrease in K+(86Rbf)-uptake of mast 
cells by 10e4 M of the lipophilic as well as the hydro- 
philic glycosides (Figs. 1 and 2) is likely to occur 
through inhibition of the activity of the Na’/K’-pump 
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Fig. 3. Effect of ouabain, Li+, and La’+ on cellular K’(86Rb+)-uptake 
and histamine release induced by compound 48/80, egg-albumin and 
substance P. The cells were preincubated for 60 min at 37°C in pres- 
ence of Li’ or La’+ as indicated. Control samples preincubated in 
normal sodium-containing medium were included. In all cases the 
concentration of potassium was 4.75 mM. Following the first preincu- 
bation period, 100 ~1 of Krebs-Ringer solution containing ouabain 
(final concentration 10m3 M) was added to the cells for an additional 
preincubation period of 60 min. Samples without ouabain were in- 
cluded. The second preincubation was followed by an incubation 
period of 10 min in presence of “Rb (for determination of the 
K’(s6Rb+)-uptake) or compound 48180, egg-albumin, substance P (for 
determination of histamine release). For the determination of sponta- 
neous histamine release, samples without the releasers were run in 
parallel. The left hand scale shows the ouabain-sensitive K’(86Rb’)- 
uptake (open columns) and the right hand scale represents the hista- 
mine release as a percentage of the total histamine content of the 
sample (hatched columns). *P < 0.05; **P < 0.01. 
[5] since this is the cellular receptor for all cardiac glyco- 
sides [9]. 
The high concentration of ouabain (10e3 M) neces- 
sary to obtain a marked inhibition of the pump activity 
(Fig. 1) can be explained on a genetic basis [lo], and this 
observation confirms previous reports on isolated rat 
Na’/K+-ATPase [11,12] and studies on cellular potas- 
sium uptake mediated by the Na’/K’-pump in rat liver 
cells [13]. The tendency of low concentrations of digi- 
talis glycosides to increase the uptake of K+(86Rb+) has 
been reported previously in cardiac tissue [14]. 
DMSO was used to dissolve digoxin and digitoxi- 
genin, and DMSO is known to inhibit the histamine 
release induced by compound 48/80 from rat peritoneal 
mast cells [15]. Because of this, the concentrations of 
digoxin and digitoxigenin was not increased above 10m4 
M. The control experiments howed that the final con- 
centration of DMSO of 1.7% (v/v) relevant at this con- 
centration of the glycosides influenced neither the hista- 
mine release nor the Na+/K’-pump activity. 
The previous findings that inhibition by ouabain of 
the pump activity in a calcium-free medium was associ- 
ated with an enhancement of the release of histamine 
[1,2,4] was also observed in this investigation with di- 
goxin but not with digitoxigenin. We have proposed 
that inhibition of the Na’/K’-pump by ouabain en- 
hanced the compound 48/80-induced histamine release 
through an increase in the intracellular sodium concen- 
tration [4]. The effect of lithium (Fig. 3) indicates that 
this mechanism is also relevant for the release of hista- 
mine induced by egg-albumin and substance P. The 
dissociation between inhibition of the Na’/K+-pump ac- 
tivity by digitoxigenin and the lack of enhancement of 
histamine release may be explained by an additional 
effect of the drug on mast cells. The lipophilic character 
of the drug makes it likely that digitoxigenin could pen- 
etrate the plasma membrane and influence the trans- 
membranal signal transduction or the fusion process of 
exocytosis. 
The enhancement of histamine release by ouabain in 
a sodium-containing medium was almost blocked by 
lanthanum. This effect may be attributed to displace- 
ment by lanthanum of membrane-bound calcium [16], 
which is considered to be involved in stimulus-secretion 
coupling [17]. 
Our data indicate a role of membrane-bound calcium 
in the mechanism by which ouabain enhances the re- 
lease of histamine by compound 48/80, substance P and 
egg-albumin from sensitized mast cells. We have sug- 
gested that ouabain increases the amount of membrane- 
bound calcium. This could occur as a consequence of 
an increased concentration of intracellular sodium. It 
has also been demonstrated that digitalis glycosides are 
able to increase the amount of calcium bound to plasma 
membranes by a mechanism independent of the inhib- 
itory effect on the Na+/K’-pump [ 181. The enhancement 
by ouabain thus seems to involve both intracellular so- 
dium and membranal calcium in the exocytotic process, 
even when different secretagogues are used. 
The low level of K’(86Rb+)-uptake in the presence of 
calcium confirm previous observations and may be ex- 
plained by an inhibitory effect of calcium on the cellular 
sodium uptake with a subsequent inhibition of the Na’/ 
K’-pump [5,19]. This mechanism may also concern the 
inhibition observed with lanthanum [20]. In the pres- 
ence of calcium in the medium ouabain had only a 
marginal effect on K’(86Rb+)-uptake [5], as also ob- 
served in this study with digoxin and digitoxigenin. 
In conclusion, in a calcium-free medium, the digitalis 
glycosides, ouabain and digoxin, increase the secretion 
of histamine from rat peritoneal mast cells induced im- 
munologically and by compound 48/80 or substance P. 
In contrast, the more lipophilic glycoside, digitoxigenin, 
either has no or a small inhibitory effect on histamine 
release. The various glycosides do not differ in their 
inhibitory effects on the Na+/K’-pump. The difference 
between the various glycosides in their effects on the 
cellular release of histamine cannot be explained in 
terms of different effects on the Na’/K’-pump, but it 
may be due to an interaction between the lipophilic 
digitoxigenin and the plasma membrane. The mecha- 
nisms responsible for the enhancing effect of ouabain on 
the cellular histamine release seem to involve an in- 
crease in intracellular sodium and changes in a mem- 
brane-bound pool of calcium. These mechanisms are 
the same whether histamine release is induced immunol- 
130 
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ogically (egg-albumin), by compound 48/80 or by sub- 
stance P. 
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